150 related articles for article (PubMed ID: 10235609)
21. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
22. Co-administration of Magnesium Ion Prevents Indomethacin-Induced Intestinal Ulcerogenic Lesions in Adjuvant-Induced Arthritis Rats.
Nagai N; Ueno A; Tanino T; Oka M; Ito Y
Biol Pharm Bull; 2017; 40(6):910-915. PubMed ID: 28566633
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, Characterization and Comparison of Local Analgesic, Anti-Inflammatory, Anti-Ulcerogenic Activity of Copper and Zinc Complexes of Indomethacin.
Sukul A; Poddar SK; Haque S; Saha SK; Das SC; Al Mahmud Z; Abdur Rahman SM
Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):221-233. PubMed ID: 28215165
[TBL] [Abstract][Full Text] [Related]
24. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
25. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice.
Souza MH; Lemos HP; Oliveira RB; Cunha FQ
Gut; 2004 Jun; 53(6):791-6. PubMed ID: 15138204
[TBL] [Abstract][Full Text] [Related]
26. Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine.
Evans SM; László F; Whittle BJ
Eur J Pharmacol; 2000 Feb; 388(3):281-5. PubMed ID: 10675738
[TBL] [Abstract][Full Text] [Related]
27. Expression of NOS II and its role in experimental small bowel ulceration in rats.
Chen K; Hirota S; Wasa M; Okada A
Surgery; 1999 Sep; 126(3):553-61. PubMed ID: 10486609
[TBL] [Abstract][Full Text] [Related]
28. 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats.
Nandi J; Saud B; Zinkievich JM; Palma DT; Levine RA
Dig Dis Sci; 2008 Jan; 53(1):123-32. PubMed ID: 17503181
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological evaluations of N-(substituted benzoylamino)-5-carbethoxymethyl-1,2,3,6-tetrahydropyridines as potential antiinflammatory agents.
Yoon K; Wilson T; Williams S; Redda K
Drugs Exp Clin Res; 2000; 26(3):73-82. PubMed ID: 10941599
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin.
Dillon CT; Hambley TW; Kennedy BJ; Lay PA; Zhou Q; Davies NM; Biffin JR; Regtop HL
Chem Res Toxicol; 2003 Jan; 16(1):28-37. PubMed ID: 12693028
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of carrageenan-induced edema by indomethacin or sodium salicylate does not prevent the increase of nerve growth factor in the rat hind paw.
Amann R; Schuligoi R
Neurosci Lett; 2000 Jan; 278(3):173-6. PubMed ID: 10653021
[TBL] [Abstract][Full Text] [Related]
32. Excessive Interleukin 18 Relate the Aggravation of Indomethacin-Induced Intestinal Ulcerogenic Lesions in Adjuvant-Induced Arthritis Rat.
Nagai N; Tanino T; Ito Y
Biol Pharm Bull; 2015; 38(10):1580-90. PubMed ID: 26424019
[TBL] [Abstract][Full Text] [Related]
33. Preparation and pharmacodynamic evaluation of liposomes of indomethacin.
Srinath P; Vyas SP; Diwan PV
Drug Dev Ind Pharm; 2000 Mar; 26(3):313-21. PubMed ID: 10738648
[TBL] [Abstract][Full Text] [Related]
34. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of inflammation and gastric damage in rats by copper (II) complexes.
Jiménez-Hernández RM; Frechilla D; Lasheras B; Gutiérrez-Ríos MT; Parrondo E; Craciunescu G; Cenarruzabeita E
Arzneimittelforschung; 1995 Mar; 45(3):277-81. PubMed ID: 7741784
[TBL] [Abstract][Full Text] [Related]
36. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in rats.
Kunikata T; Miyazawa T; Kanatsu K; Kato S; Takeuchi K
Jpn J Pharmacol; 2002 Jan; 88(1):45-54. PubMed ID: 11855677
[TBL] [Abstract][Full Text] [Related]
38. Increased susceptibility of small intestine to NSAID-provoked ulceration in rats with adjuvant-induced arthritis: involvement of enhanced expression of TLR4.
Kato S; Ito Y; Nishio H; Aoi Y; Amagase K; Takeuchi K
Life Sci; 2007 Sep; 81(16):1309-16. PubMed ID: 17920637
[TBL] [Abstract][Full Text] [Related]
39. Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: The role of nitric oxide.
Florentino IF; Silva DPB; Silva DM; Cardoso CS; Moreira ALE; Borges CL; Soares CMA; Galdino PM; Lião LM; Ghedini PC; Menegatti R; Costa EA
Nitric Oxide; 2017 Sep; 69():35-44. PubMed ID: 28412475
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
